Tempest Therapeutics Inc (NASDAQ: TPST) is 7.00% higher on its value in year-to-date trading and has touched a low of $0.70 and a high of $6.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TPST stock was last observed hovering at around $0.92 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.89, the stock is 3.86% and -1.20% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.98 million and changing -2.83% at the moment leaves the stock -53.30% off its SMA200. TPST registered -78.89% loss for a year compared to 6-month loss of -59.78%. The firm has a 50-day simple moving average (SMA 50) of $0.9042 and a 200-day simple moving average (SMA200) of $1.926975.
The stock witnessed a 6.99% gain in the last 1 month and extending the period to 3 months gives it a -16.55%, and is -5.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.36% over the week and 10.43% over the month.
Tempest Therapeutics Inc (TPST) has around 17 employees, a market worth around $38.97M and $0.00M in sales. Distance from 52-week low is 27.81% and -85.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-178.81%).
The EPS is expected to grow by 29.54% this year
30.0 institutions hold shares in Tempest Therapeutics Inc (TPST), with institutional investors hold 23.07% of the company’s shares. The shares outstanding are 43.64M, and float is at 39.62M with Short Float at 6.56%. Institutions hold 23.02% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.55 million shares valued at $1.21 million. The investor’s holdings represent 2.4747 of the TPST Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 0.43 million shares valued at $0.95 million to account for 1.9426 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 0.18 million shares representing 0.7924 and valued at over $0.39 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.6937 of the shares totaling 0.15 million with a market value of $0.34 million.
Tempest Therapeutics Inc (TPST) Insider Activity
Tempest Therapeutics Inc disclosed in a document filed with the SEC on Aug 08 ’24 that Versant Venture Capital VI, L. (10% Owner) sold a total of 400,000 shares of the company’s common stock. The trade occurred on Aug 08 ’24 and was made at $1.35 per share for $0.54 million. Following the transaction, the insider now directly holds 0.6 million shares of the TPST stock.
Still, SEC filings show that on Aug 12 ’24, Versant Venture Capital VI, L. (10% Owner) disposed off 387,999 shares at an average price of $1.10 for $0.43 million. The insider now directly holds 209,941 shares of Tempest Therapeutics Inc (TPST).
